Can a digital dispenser solve the pill problem for patients with multiple diseases?
NCT ID NCT07175545
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study tests Mobili®, a portable digital dispenser that automatically gives the right pills at the right time. Researchers will enroll 96 adults with diabetes or heart disease who take at least two daily medications. Participants use the device for a period, and the study measures how many pills are taken correctly, along with blood sugar and blood pressure levels. The goal is to see if this technology, supported by pharmacists, can improve medication adherence and health outcomes.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Mobili® digital medication dispenser (device)
What this could lead to
If successful, this could provide a practical tool to help people with multiple chronic conditions take their medications correctly, reducing complications and hospital visits.
What could go wrong
This is a small, early-stage crossover trial with only 96 participants. The device requires smartphone use, which may limit who can benefit. Results may not apply to broader populations.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CARDIOVASCULAR DISEASES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Universidade Lusófona - Centro Universitário de Lisboa
Lisbon, 1749-024, Portugal
Contact Phone: •••-•••-•••• Email: •••••@•••••